Navigation Links
Quadruple therapy shows 100 percent SVR for HCV patients previously unresponsive to treatment
Date:4/2/2011

Berlin, Germany, Saturday 02 April 2011: Exciting new data presented today at the International Liver CongressTM 2011 show that quadruple therapy in chronic hepatitis C (HCV) patients suppressed the emergence of resistant variants and resulted in a 100% rate of sustained virological response - undetectable HCV RNA - 12 weeks after treatment (SVR12).1

In the quadruple therapy study, HCV patients were given four drugs in combination; pegylated Interferon-alpha (PegIFN-alpha); ribavirin (RBV); and two different direct-acting antivirals (DAAs) BMS-650032 (an HCV NS3 protease inhibitor) and BMS-790052 (an HCV NS5A replication complex inhibitor).

The current standard of care (SoC) for HCV therapy is PegIFN-alpha plus RBV a dual therapy. The addition of DAAs (currently in phase-III clinical trials) marks the next step in treatment evolution a triple therapy. However, the new data presented today suggests that quadruple therapy could be the next generation of treatment for chronic HCV patients.

Professor Heiner Wedemeyer, EASL'S Secretary General, said: "Quadruple therapy is possibly the future of HCV treatment; this study goes a way to confirming that. While it's expected that the first DAAs and triple therapy will be approved for use later this year, quadruple therapy appears to have a more profound effect on virological response, with less of a resistance problem."

The study may also provide new hope for a growing number of HCV patients who cannot be effectively treated for chronic hepatitis with current treatments.

The Phase-IIa trial looked at a cohort of 21 HCV genotype 1 null responders (patients who have failed to respond to previous treatment), of whom 19 had an unfavourable IL28B genotype, which predisposes HCV patients to treatment failure.

Only about 30% of null responders to PegIFN-alpha/RBV treatment achieve sustained virological response (SVR) when retreated with PegIFN-alpha/RBV plus telaprevir,
'/>"/>

Contact: Travis Taylor
easlpressoffice@cohnwolfe.com
44-784-306-9451
European Association for the Study of the Liver
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Insulin could be Alzheimers therapy
2. Early Brain Therapy May Help Movement in Dystonia Patients
3. New approach to leukemia chemotherapy -- is a cure in sight?
4. Benefits of Radiation Therapy Outweigh Risks of a Second Cancer: Study
5. New Therapy for Enlarged Prostate May Bypass Unpleasant Side Effects
6. For potentially crippling dystonia, earlier deep brain therapy gets better, quicker results
7. Scientists devise targeted therapy strategy for rare form of childhood cancer
8. FDA approves ipilimumab, an immunotherapy, to treat metastatic melanoma
9. Novel immunotherapy drug receives FDA approval for the treatment of metastatic melanoma
10. Interest in Toys May Predict Success of Autism Home Therapy
11. Short Course of Hormone Therapy Boosts Prostate Cancer Survival: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2014)... Calif. Consider the marvel of the embryo. It begins ... function as they multiply to become the cells of our ... the body. , Now, in a feat of reverse tissue ... genetic coding that allows embryonic cells to proliferate and transform ...
(Date:4/16/2014)... A team that includes scientists from the School of ... San Antonio, Johns Hopkins University and St. Mary,s University reported ... to infect the body. , The fungal pathogen Candida ... and is the most common fungal pathogen to infect humans. ...
(Date:4/15/2014)... in the United States have nearly doubled since 1988, suggests ... Health, with obesity apparently to blame for the surge. The ... not hit all groups equally, with alarming increases in diabetes ... research reported in the April 15, 2014 issue of the ...
(Date:4/15/2014)... , In a recent analysis by the RECIST Working Group ... researchers had explored whether a more refined categorization of tumor ... overall survival in the RECIST database. They found that ... of overall survival above and beyond that of the other ...
(Date:4/14/2014)... South Africa may provide insight on how to identify and ... the world, which may have limited access to healthcare and ... A report on the global AIDS epidemic published by the ... has left 12 million children orphaned in Sub-Saharan African, children ...
Breaking Medicine News(10 mins):Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 3Health News:Pre-diabetes and diabetes nearly double over the past 2 decades 2Health News:Can refined categorization improve prediction of patient survival in RECIST 1.1? 2Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3
... for health care reform programs will result in the potential ... coverage in California, according to a new policy brief from ... The number represents approximately 20 percent of all uninsured children ... 40,000 may be eligible for coverage but may not apply, ...
... 2011) Autism Speaks, the world,s largest autism science ... for Autism have joined HP,s "Hacking Autism" initiative, which ... people with autism. "Hacking Autism" will crowd source ideas ... families and practitioners, and will engage developers and designers ...
... young adult mice that a lone brain stem cell is capable ... and glia important types of brain cells but also ... cells. A report on their study appears June 24 in ... has the capacity to generate both neurons, which send and receive ...
... , THURSDAY, June 30 (HealthDay News) -- Cotton swabs ... infections, according to researchers. Daily use of dry ... patients who,d undergone appendectomy dramatically reduced surgical site infections, ... underwent the daily routine developed infections, compared with 19 ...
... , THURSDAY, June 30 (HealthDay News) -- The number of ... levels has dropped by more than half over the past ... 6.3 per 100,000 in 2009, a new study reveals. ... decreased, the health effects from lead exposure are well characterized," ...
... the Sahlgrenska Academy, University of Gothenburg, have identified a ... The proteins, which carry specific sugar molecules, are found ... Alzheimer,s disease than in patients with dementia caused by ... treatment in the future. , Gran Larson is a ...
Cached Medicine News:Health News:Up to 220,000 California children excluded from health care reform due to immigrant status 2Health News:Autism Speaks and Flutie Foundation join HP's 'Hacking Autism' to develop touch apps for autism 2Health News:Autism Speaks and Flutie Foundation join HP's 'Hacking Autism' to develop touch apps for autism 3Health News:Nervous system stem cells can replace themselves, give rise to variety of cell types, even amplify 2Health News:Cotton Swabs Help Prevent Surgical Site Infections: Study 2Health News:On-the-Job Lead Exposures Falling, But Still a Problem: CDC 2Health News:New clues to the cause of Alzheimer's disease 2
(Date:1/15/2014)... THOUSAND OAKS, Calif. , Jan. 15, 2014 ... and Amgen (NASDAQ: AMGN ) announced ... to jointly discover and validate new therapeutic targets ... (IBD), a chronic disorder that affects millions worldwide. ...
(Date:1/15/2014)... FORT WORTH, Texas , Jan. 15, 2014  Humberto ... in Dermatology Achievement Award" from the Journal of ... Dermatology Aesthetic & Clinical Conference (ODAC). The event is January ... Florida . The ...
(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014  Manufacturers, ... technologies must be able to protect their most ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because ... Industry, it steadfastly remains one of the most ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Intellectual Property Insurance for Medical-related Products and Services 2
Inquire...
Sterilization: sterilized Yes...
Transparent film for easy visual monitoring of samples...
Microporous tape sheets for covering 96-well plates, square-well or flat-bottom blocks.;...
Medicine Products: